Exocrine Pancreatic Insufficiency in Diabetes Mellitus: Incidence, Pathogenesis, Diagnosis and Treatment
Journal Title: Гастроентерологія - Year 2015, Vol 1, Issue 55
Abstract
The article deals with exocrine pancreatic insufficiency (EPI), which is being detected in a significant number (30–50 %) of patients with diabetes mellitus (DM) type I and II and could potentially affect the compensation of DM. Enzyme replacement therapy should be considered as one of the most promising treatments in patients with DM. This therapy is preferably to be carried out in accordance with clinical guidelines set out in the recent consensuses, however, with higher doses of modern fourth-generation enzyme preparations such as Pangrol® 25000. Additional methods of treatment for EPI in patients with DM are correction of nutritional status using appropriate diet, as well as vitamin replacement therapy.
Authors and Affiliations
S. M. Tkach
Chronic inflammatory bowel diseases: epidemiological features in Ukraine
Background. The number of registered patients with inflammatory bowel diseases (IBD) that is characterized by systemic manifestations and polymorbidal course is increasing nowadays. IBD, which include ulcerative colitis...
Dysfunction of the biliary tract in children: traditional approaches and new postulates
Digestive system diseases take one of the leading places in the structure of somatic pathology of childhood. Functional disorders of the biliary tract is a set of clinical symptoms, which developed as a result of motor-t...
On the Question of Differential Diagnosis of Malabsorption Syndromes (lactase insufficiency, gluten intolerance, celiac disease)
.
Optimizing of duodenogastric reflux therapy in patients with chronic gastritis
Background. The known methods of duodenogastric reflux treatment which include prokinetics administration against the background of chronic gastritis standard therapy, as a rule, have the low therapeutic efficacy. The ai...
The Efficacy of Eradication of Helicobacter pylori Infection in Primary Prevention of NSAID-induced Gastropathy
With the aim of clarifying the efficacy of eradication therapy for Helicobacter pylori (Hp) infection in primary prevention of NSAID-induced gastropathy, we have examined 39 Hp-positive patients, in whom we planned to ad...